Pancreatic Cancer Early Detection Program

  • STATUS
    Recruiting
  • End date
    Mar 19, 2024
  • participants needed
    100
  • sponsor
    White Plains Hospital
Updated on 19 March 2021
cancer
endoscopic ultrasound
cancer screening
BRCA1
ATM
BRCA2
pancreatitis
palb2
familial cancer
spink1

Summary

Early detection testing is recommended for individuals at elevated risk for the development of Pancreatic Cancer. This Protocol will define sufficiently elevated risk as either equal to or greater than five times the general population risk, or five times the average risk (1.5%) of developing pancreatic cancer by age 70; that is a 7.5% lifetime risk. Our inclusion criteria has a strong focus on the risk for pancreatic cancer imparted by the presence of hereditary cancer genes, as well as by family history. Enrolled subjects will undergo Endoscopic Ultrasound (EUS) alternating with Magnetic Resonance Imaging (MRI), every six to 12 months, for up to 5 years.

Description

Interested individuals can be referred by physicians, or by family or friends.

Individuals are informed that the purpose of this study is to collect outcome data following early detection testing based upon our criteria for elevated risk.

Consent is obtained by any of the co-investigators. Consent is obtained for the primary PCEDP, and also obtained to allow for data to be used by our Cancer Program.

We have a weekly review of all calls made and of all enrollments.

We have a monthly meeting to review all proceeding regarding the study.

Our IRB routinely reviews the proceedings of the study

Our institution has a monthly Clinical research Committee meeting.

Details
Condition Pancreatic Cancer, Pancreatic Cancer, Islet Ce417ll Cancer, Lentigo, Age Spots (Solar Lentigines), msh2 gene, Colorectal Cancer, Colorectal Cancer, Colon Cancer Screening, Colon cancer; rectal cancer, Lynch Syndrome, Peutz-Jeghers Syndrome, msh2 gene, Pancreatic disorder, Pancreatic Disorders, msh2 gene, msh2 gene, Hereditary Neoplastic Syndrome, Hereditary Cancer Syndromes, Dysplastic Nevus, Neoplasm of unspecified nature of digestive system, Digestive System Neoplasms, Pancreatic Disorders, Age Spots (Solar Lentigines), Colon Cancer Screening, Colon cancer; rectal cancer, Pancreatic Adenocarcinoma, Familial Pancreatic Cancer, Hereditary Pancreatitis, BRCA 1/2, FAMMM, Islet Ce417ll Cancer, Hereditary Cancer Syndromes, Digestive System Neoplasms, BRCA 1/2, BRCA 1/2, BRCA 1/2, BRCA 1/2, BRCA 1/2, MLH1, hnpcc, cancer of the pancreas, pancreatic cancers, cancer, pancreatic, BRCA 1/2, BRCA 1/2, BRCA 1/2
Treatment Magnetic Resonance Imaging (MRI), Endoscopic Ultrasound, Endoscopic Ultrasound
Clinical Study IdentifierNCT02206360
SponsorWhite Plains Hospital
Last Modified on19 March 2021

Eligibility

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note